University of Pennsylvania, Division of Reproductive Endocrinology and Infertility, Philadelphia, PA, USA.
Sibel Health, Niles, IL, USA.
Sleep Med. 2022 Dec;100:511-517. doi: 10.1016/j.sleep.2022.09.026. Epub 2022 Oct 12.
To study the feasibility of home-based assessment of sleep disordered breathing (SDB) on early pregnancy success after in vitro fertilization with novel wearable sensors.
Prospective observational study.
Patients 18 to 45 years old undergoing autologous IVF at an academic infertility center.
30 women (24-44 years old) INTERVENTION: Participants provided medical history, completed sleep surveys, and a single night of home sleep monitoring prior to IVF with a novel, FDA-cleared wireless sensor system (ANNE® Sleep, Sibel Health), to collect continuous measurements of heart rate, respiratory rate, pulse oxygenation, respiratory effort/snoring, peripheral arterial tonometry, pulse arrival time, and pulse transit time, an accepted surrogate of continuous blood pressure generated by pulse arrival time and pulse transit time. Sleep nights were reviewed to derive the apnea hypopnea index (AHI), defined as the average number of apnea or hypopnea events per hour. An AHI of greater than or equal to 5 events/hour was considered abnormal.
Rate of clinical pregnancy (defined as intrauterine gestational sac with a yolk sac) after IVF. Logistic regression models were used to estimate the unadjusted and adjusted odds ratio.
The overall rate of sleep disordered breathing of any severity was 57%. Participants with SDB had a mean AHI of 13.4 compared to 2.7 events/hr (p<0.01), were younger, and more likely to have polycystic ovary syndrome. Of the 29 patients undergoing an embryo transfer, clinical pregnancy and livebirth occurred in 35% of women with SDB compared to 58% without SDB (p = 0.22). After adjusting for age, SDB reduced pregnancy rates but was not statistically significant (aOR 0.23, 95% CI: 0.04-1.5, p = 0.12). Though polycystic ovary syndrome was associated with higher rates of SDB it was not independently associated with lower pregnancy rates.
Screening for sleep disordered breathing using home-based wireless, wearable sensors was well accepted and easily performed by infertile patients in this cohort. Sleep disordered breathing of any severity was associated with an 77% (95% CI: 0.08-1.8) lower likelihood of clinical pregnancy and live birth independent of underlying diagnosis. Future larger studies will be needed to understand the role of sleep disordered breathing and IVF outcomes.
研究新型可穿戴传感器在体外受精(IVF)后对妊娠早期成功的睡眠障碍性呼吸(SDB)的家庭评估的可行性。
前瞻性观察性研究。
在学术不孕不育中心接受自体 IVF 的 18 至 45 岁的患者。
30 名女性(24-44 岁)
参与者提供病史,完成睡眠调查,并在 IVF 前使用新型经过 FDA 批准的无线传感器系统(ANNE®Sleep,Sibel Health)进行单晚家庭睡眠监测,以连续测量心率、呼吸率、脉搏血氧饱和度、呼吸努力/打鼾、外周动脉张力、脉搏到达时间和脉搏传输时间,这是一种通过脉搏到达时间和脉搏传输时间生成的连续血压的可接受替代物。回顾睡眠之夜以得出呼吸暂停低通气指数(AHI),定义为每小时呼吸暂停或低通气事件的平均次数。AHI 大于或等于 5 次/小时被认为是异常的。
IVF 后的临床妊娠率(定义为宫内妊娠囊伴卵黄囊)。使用逻辑回归模型估计未调整和调整后的优势比。
任何严重程度的睡眠障碍呼吸的总体发生率为 57%。患有 SDB 的参与者的平均 AHI 为 13.4,而 2.7 次/小时(p<0.01),年龄较小,且更有可能患有多囊卵巢综合征。在 29 名接受胚胎移植的患者中,患有 SDB 的女性的临床妊娠和活产率为 35%,而无 SDB 的女性为 58%(p=0.22)。调整年龄后,SDB 降低了妊娠率,但无统计学意义(aOR 0.23,95%CI:0.04-1.5,p=0.12)。尽管多囊卵巢综合征与更高的 SDB 发生率相关,但与较低的妊娠率无关。
使用基于家庭的无线可穿戴传感器筛查睡眠障碍呼吸在该队列的不孕患者中得到了很好的接受和易于实施。任何严重程度的睡眠障碍呼吸与临床妊娠和活产的可能性降低 77%(95%CI:0.08-1.8)独立相关,而与潜在诊断无关。未来需要更大的研究来了解睡眠障碍呼吸和 IVF 结果的作用。